AstraZeneca rare disease drug fails key trial tests
Anselamimab, which AstraZeneca acquired via Caelum Biosciences, missed its primary goal in two late-stage trials, but appeared to have some benefit in a subgroup of patients.
Anselamimab, which AstraZeneca acquired via Caelum Biosciences, missed its primary goal in two late-stage trials, but appeared to have some benefit in a subgroup of patients.
In the rapidly evolving field of plant molecular biology, a groundbreaking study by Caballero-Carretero and Medina published in Nature Plants (2025) unveils a mobile transcription factor that orchestrates systemic responses to nitrogen deficiency across the plant. This discovery not only deepens our fundamental understanding of nutrient signaling in plants but also opens transformative avenues for … Read more
Can a Cough Syrup Save Your Memory? Scientists Test It for Parkinson’s Disease Dementia! A common drug, recognized for treating symptoms such as colds and chest congestion, has become a hero in the Neuroscience landscape. This heroic attention was grabbed by “Ambroxol.” This Cough Syrup is prescribed to patients for relieving congestion and coughs. This … Read more
Platform integrating brain-structure-mimicking neural network model construction and functional measurement technology. Credit: Biosensors and Bioelectronics (2025). DOI: 10.1016/j.bios.2025.117688 Existing three-dimensional (3D) neuronal culture technology has limitations in brain research due to the difficulty of precisely replicating the brain’s complex multilayered structure and the lack of a platform that can simultaneously analyze both structure and function. … Read more
States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government to negotiate pay-for-performance deals with the manufacturers of products like Casgevy and Lyfgenia.
In the ever-evolving field of microbiology, the ability to accurately identify and quantify the myriad species inhabiting diverse environments has long been a formidable challenge. Metagenomics, the study of genetic material recovered directly from environmental samples, promises unprecedented insights into microbial communities across global ecosystems—from ocean depths to soil strata, and even human microbiomes. However, … Read more
Newsletter Signup – Under Article / In Page “*” indicates required fields While we mostly think of disease as being caused by external factors like bacteria and viruses, an illness can also occur when the body’s own defenses turn against themselves. In this article, we take a look at some rare autoimmune diseases you may … Read more
Space Based Drug Discovery – Varda Space Industries Imagine a future where the most life-saving medicines and drugs aren’t made in a laboratory on Earth, but in orbit, where gravity no longer limits what we can create. In a quiet corner of California, a group of researchers, Engineers, and Dreamers is turning this futuristic idea … Read more
Three-dimensional (3D) thermal imaging in vivo. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-59681-7 A team of researchers from Ca’ Foscari University of Venice and the Universidad Autónoma de Madrid has developed a groundbreaking technique that maps temperature in three dimensions within biological tissue, using invisible light and artificial intelligence. The approach, just published in Nature Communications, … Read more
Inorganic perovskite solar cells have rapidly gained traction as promising candidates for next-generation photovoltaic technologies, chiefly due to their exceptional optoelectronic properties and superior thermal stability compared to their organic–inorganic hybrid counterparts. Yet, despite the impressive efficiencies demonstrated, their long-term operational stability remains a pivotal bottleneck precluding widespread commercial adoption. A recent breakthrough study by … Read more